Form 4 holding
COO and ICEO and IP, 10%+ Owner
Immune Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 15,607,998
- Estimated value
- Report date
- 25 Jul 2022
- Price
- Ownership
- By Murphy Advisors, Inc.
Kelly O'Brien Wilson - COO and ICEO and IP, 10%+ Owner at Biostax Corp.
Issuer-level insider activity
- Role
- COO and ICEO and IP, 10%+ Owner
- Issuer ticker
- IMUN
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Kelly O'Brien Wilson since 04 Aug 2025
Reported holdings for Kelly O'Brien Wilson in Biostax Corp.
Form 4 holding
COO and ICEO and IP, 10%+ Owner
Immune Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,696,947
- Estimated value
- Report date
- 25 Jul 2022
- Price
- Ownership
- By spouse
Form 4 holding
COO and ICEO and IP, 10%+ Owner
Immune Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 500
- Estimated value
- Report date
- 25 Jul 2022
- Price
- Ownership
- Direct
Transaction history for Kelly O'Brien Wilson in Biostax Corp.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.